Target Price | $527.20 |
Price | $413.42 |
Potential | 27.52% |
Number of Estimates | 15 |
15 Analysts have issued a price target MicroStrategy 2026 . The average MicroStrategy target price is $527.20. This is 27.52% higher than the current stock price. The highest price target is $650.00 57.23% , the lowest is $175.00 57.67% . | |
A rating was issued by 17 analysts: 16 Analysts recommend MicroStrategy to buy, 0 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MicroStrategy stock has an average upside potential 2026 of 27.52% . Most analysts recommend the MicroStrategy stock at Purchase. |
13 Analysts have issued a sales forecast MicroStrategy 2025 . The average MicroStrategy sales estimate is $463m . This is 0.77% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $477m 3.84% , the lowest is $443m 3.54% .
This results in the following potential growth metrics:
2024 | $463m | 6.61% |
---|---|---|
2025 | $463m | 0.14% |
2026 | $483m | 4.30% |
2027 | $478m | 0.97% |
2028 | $454m | 5.09% |
2029 | $476m | 5.00% |
5 Analysts have issued an MicroStrategy EBITDA forecast 2025. The average MicroStrategy EBITDA estimate is $41.0m . This is 212.15% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $55.4m 251.70% , the lowest is $27.5m 175.30% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-24.5m | 176.49% |
---|---|---|
2025 | $41.0m | 266.97% |
2026 | $57.0m | 39.23% |
2024 | -5.29% | 181.90% |
---|---|---|
2025 | 8.85% | 267.21% |
2026 | 11.81% | 33.45% |
5 MicroStrategy Analysts have issued a net profit forecast 2025. The average MicroStrategy net profit estimate is $-4.3b . This is 25.36% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-4.2b 27.88% , the lowest is $-4.5b 23.06% .
This results in the following potential growth metrics and future Net Margins:
2024 | $-1.6b | 329.55% |
---|---|---|
2025 | $-4.3b | 168.61% |
2026 | $-103m | 97.61% |
2027 | $-144m | 38.97% |
2024 | -348.05% | 345.79% |
---|---|---|
2025 | -936.23% | 169.00% |
2026 | -21.43% | 97.71% |
2027 | -30.07% | 40.32% |
5 Analysts have issued a MicroStrategy forecast for earnings per share. The average MicroStrategy EPS is $-16.28 . This is 25.36% higher than earnings per share in the financial year 2024. The highest EPS forecast is $-15.73 27.88% , the lowest is $-16.78 23.06% .
This results in the following potential growth metrics and future valuations:
2024 | $-6.06 | 329.55% |
---|---|---|
2025 | $-16.28 | 168.65% |
2026 | $-0.39 | 97.60% |
2027 | $-0.54 | 38.46% |
Current | -18.95 | 91.99% |
---|---|---|
2025 | -25.40 | 34.04% |
2026 | -1,063.95 | 4,088.78% |
2027 | -765.59 | 28.04% |
Based on analysts' sales estimates for 2025, the MicroStrategy stock is valued at an EV/Sales of 264.62 and an P/S ratio of 244.23 .
This results in the following potential growth metrics and future valuations:
Current | 266.65 | 312.64% |
---|---|---|
2025 | 264.62 | 0.76% |
2026 | 253.72 | 4.12% |
2027 | 256.19 | 0.97% |
2028 | 269.93 | 5.36% |
2029 | 257.07 | 4.76% |
Current | 246.10 | 328.71% |
---|---|---|
2025 | 244.23 | 0.76% |
2026 | 234.17 | 4.12% |
2027 | 236.45 | 0.97% |
2028 | 249.13 | 5.36% |
2029 | 237.26 | 4.76% |
Analyst | Rating | Action | Date |
---|---|---|---|
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | May 05 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 05 2025 |
HC Wainwright & Co. |
Buy
➜
Buy
|
Unchanged | May 02 2025 |
Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | May 02 2025 |
HC Wainwright & Co. |
➜
Buy
|
Initiated | Apr 29 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 10 2025 |
Keefe, Bruyette & Woods |
➜
Outperform
|
Initiated | Feb 07 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
May 05 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 05 2025 |
Unchanged
HC Wainwright & Co.:
Buy
➜
Buy
|
May 02 2025 |
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
May 02 2025 |
Initiated
HC Wainwright & Co.:
➜
Buy
|
Apr 29 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 10 2025 |
Initiated
Keefe, Bruyette & Woods:
➜
Outperform
|
Feb 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.